SlideShare a Scribd company logo
1 of 6
Dr. Reddy’s Laboratories November 28, 2009 Presented by:  Group 3 Anshul Gupta Govind Singh Jatinder Pal Singh Puneet Piyush Sachin Sharma Vaibhav Awasthi Submitted to: Prof. A.P. Das
Accounting Reporting Practices ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],The initiatives taken by Dr. Reddy’s towards adopting with various accounting policies (including SOX, IFRS and Indian GAAP) ensures that all stakeholders have full confidence in the overall `practices of the Company Source: Company report Key Practices
Financial Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],2009 Global Generics revenue increased by 51%, primarily on account of the launch of ‘sumatriptan’ in North America and strong performance in Russia and CIS 2008 2008 2009 The revenue composition between geographies changed considerably primarily due to sale of ‘sumatriptan’ in the US Source: Company report Note: Analysis as per IFRS Financial Highlights Segmental Breakdown: By Business Segmental Breakdown: By Geography
Important Disclosures ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: Company report Key Disclosures & General Practices
Corporate Governance ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Timely disclosures, transparent accounting policies and a strong and independent Board go a long way in preserving shareholders trust while maximizing long-term corporate values Source: Company website, Company report Key Framework
Thank You

More Related Content

What's hot

Betapharm's acquisition by Dr Reddy's Lab
Betapharm's acquisition by Dr Reddy's LabBetapharm's acquisition by Dr Reddy's Lab
Betapharm's acquisition by Dr Reddy's Lab
Anirban Dutta
 
Glenmark pharma ppt final
Glenmark pharma ppt finalGlenmark pharma ppt final
Glenmark pharma ppt final
Suraj Warthy
 
Shasun Pharmaceuticals
Shasun PharmaceuticalsShasun Pharmaceuticals
Shasun Pharmaceuticals
Karthik Varma
 
Financial analysis of novartis pharmaceuticals
Financial analysis of novartis pharmaceuticalsFinancial analysis of novartis pharmaceuticals
Financial analysis of novartis pharmaceuticals
yashicaj9
 
Product Mix of Dr. Reddy's
Product Mix of Dr. Reddy'sProduct Mix of Dr. Reddy's
Product Mix of Dr. Reddy's
Animesh Gupta
 

What's hot (20)

DR REDDYS LABS PPT
DR REDDYS LABS PPTDR REDDYS LABS PPT
DR REDDYS LABS PPT
 
Dr. Reddy's Lab - Business Model
Dr. Reddy's Lab - Business ModelDr. Reddy's Lab - Business Model
Dr. Reddy's Lab - Business Model
 
Presented by buddhabhushan reddy.new
Presented by  buddhabhushan reddy.newPresented by  buddhabhushan reddy.new
Presented by buddhabhushan reddy.new
 
Betapharm's acquisition by Dr Reddy's Lab
Betapharm's acquisition by Dr Reddy's LabBetapharm's acquisition by Dr Reddy's Lab
Betapharm's acquisition by Dr Reddy's Lab
 
1
11
1
 
Dr. Reddy's Laboratories
Dr. Reddy's LaboratoriesDr. Reddy's Laboratories
Dr. Reddy's Laboratories
 
Strategic Management Group Presentation
Strategic Management Group PresentationStrategic Management Group Presentation
Strategic Management Group Presentation
 
Dr Reddys Corporate Brochure
Dr Reddys Corporate BrochureDr Reddys Corporate Brochure
Dr Reddys Corporate Brochure
 
Lupin
LupinLupin
Lupin
 
Glenmark pharma ppt final
Glenmark pharma ppt finalGlenmark pharma ppt final
Glenmark pharma ppt final
 
The MPS at GSK
The MPS at GSKThe MPS at GSK
The MPS at GSK
 
Shasun Pharmaceuticals
Shasun PharmaceuticalsShasun Pharmaceuticals
Shasun Pharmaceuticals
 
Ranbaxy
RanbaxyRanbaxy
Ranbaxy
 
Financial analysis of novartis pharmaceuticals
Financial analysis of novartis pharmaceuticalsFinancial analysis of novartis pharmaceuticals
Financial analysis of novartis pharmaceuticals
 
Beximco and its Short Term Financing
Beximco and its Short Term Financing Beximco and its Short Term Financing
Beximco and its Short Term Financing
 
Case Study Analysis on GlaxoSmithkline
Case Study Analysis on GlaxoSmithklineCase Study Analysis on GlaxoSmithkline
Case Study Analysis on GlaxoSmithkline
 
IPCA Labs
IPCA LabsIPCA Labs
IPCA Labs
 
Pfizer Strategic Analysis
Pfizer Strategic AnalysisPfizer Strategic Analysis
Pfizer Strategic Analysis
 
Pfizer-a pharmaceutical company
Pfizer-a pharmaceutical companyPfizer-a pharmaceutical company
Pfizer-a pharmaceutical company
 
Product Mix of Dr. Reddy's
Product Mix of Dr. Reddy'sProduct Mix of Dr. Reddy's
Product Mix of Dr. Reddy's
 

Similar to Dr Reddys Analysis V1.1

Financial Analysis of J Sainsbury Plc
Financial Analysis of J Sainsbury PlcFinancial Analysis of J Sainsbury Plc
Financial Analysis of J Sainsbury Plc
Jitender Barna
 
BUSI 650Integrative Learning Project – Annotated Bibliography Gr
BUSI 650Integrative Learning Project – Annotated Bibliography GrBUSI 650Integrative Learning Project – Annotated Bibliography Gr
BUSI 650Integrative Learning Project – Annotated Bibliography Gr
VannaSchrader3
 
A Study of Disclosure of Accounting Policies in BAJAJ Allianz Insurance Compa...
A Study of Disclosure of Accounting Policies in BAJAJ Allianz Insurance Compa...A Study of Disclosure of Accounting Policies in BAJAJ Allianz Insurance Compa...
A Study of Disclosure of Accounting Policies in BAJAJ Allianz Insurance Compa...
employee goverment
 
Financial ReportingAnas Alzadjali ST10299Rosli
Financial ReportingAnas Alzadjali ST10299RosliFinancial ReportingAnas Alzadjali ST10299Rosli
Financial ReportingAnas Alzadjali ST10299Rosli
ChereCheek752
 
The Shifting Pharmaceutical Industry Landscape
The Shifting Pharmaceutical Industry LandscapeThe Shifting Pharmaceutical Industry Landscape
The Shifting Pharmaceutical Industry Landscape
Phil Howard
 
Auditor and Director Reports
Auditor and Director ReportsAuditor and Director Reports
Auditor and Director Reports
gourab27
 
LPL_Presentation_-_Q2_2015_William_Blair_-_FINAL
LPL_Presentation_-_Q2_2015_William_Blair_-_FINALLPL_Presentation_-_Q2_2015_William_Blair_-_FINAL
LPL_Presentation_-_Q2_2015_William_Blair_-_FINAL
Tony Palazzo
 
8Non-GAAPs MeasuresNameProfessor’s NameCourse NameCo.docx
8Non-GAAPs MeasuresNameProfessor’s NameCourse NameCo.docx8Non-GAAPs MeasuresNameProfessor’s NameCourse NameCo.docx
8Non-GAAPs MeasuresNameProfessor’s NameCourse NameCo.docx
sleeperharwell
 

Similar to Dr Reddys Analysis V1.1 (20)

Financial Analysis of J Sainsbury Plc
Financial Analysis of J Sainsbury PlcFinancial Analysis of J Sainsbury Plc
Financial Analysis of J Sainsbury Plc
 
BUSI 650Integrative Learning Project – Annotated Bibliography Gr
BUSI 650Integrative Learning Project – Annotated Bibliography GrBUSI 650Integrative Learning Project – Annotated Bibliography Gr
BUSI 650Integrative Learning Project – Annotated Bibliography Gr
 
Introduction-to-Financial-Reporting.pptx
Introduction-to-Financial-Reporting.pptxIntroduction-to-Financial-Reporting.pptx
Introduction-to-Financial-Reporting.pptx
 
A Study of Disclosure of Accounting Policies in BAJAJ Allianz Insurance Compa...
A Study of Disclosure of Accounting Policies in BAJAJ Allianz Insurance Compa...A Study of Disclosure of Accounting Policies in BAJAJ Allianz Insurance Compa...
A Study of Disclosure of Accounting Policies in BAJAJ Allianz Insurance Compa...
 
Pooja 1
Pooja 1 Pooja 1
Pooja 1
 
IFC Act White paper
IFC Act White paperIFC Act White paper
IFC Act White paper
 
Midterm Output - AUDIT SIMULATION - GROUP 7
Midterm Output - AUDIT SIMULATION - GROUP 7Midterm Output - AUDIT SIMULATION - GROUP 7
Midterm Output - AUDIT SIMULATION - GROUP 7
 
Chapter05
Chapter05Chapter05
Chapter05
 
Financial ReportingAnas Alzadjali ST10299Rosli
Financial ReportingAnas Alzadjali ST10299RosliFinancial ReportingAnas Alzadjali ST10299Rosli
Financial ReportingAnas Alzadjali ST10299Rosli
 
The Shifting Pharmaceutical Industry Landscape
The Shifting Pharmaceutical Industry LandscapeThe Shifting Pharmaceutical Industry Landscape
The Shifting Pharmaceutical Industry Landscape
 
corporate governance
corporate governancecorporate governance
corporate governance
 
Financial Analysis
Financial AnalysisFinancial Analysis
Financial Analysis
 
Auditor and Director Reports
Auditor and Director ReportsAuditor and Director Reports
Auditor and Director Reports
 
Jazzit Score sample_32_page_report
Jazzit Score sample_32_page_reportJazzit Score sample_32_page_report
Jazzit Score sample_32_page_report
 
Jazzit score sample_32_page_report
Jazzit score sample_32_page_reportJazzit score sample_32_page_report
Jazzit score sample_32_page_report
 
LPL_Presentation_-_Q2_2015_William_Blair_-_FINAL
LPL_Presentation_-_Q2_2015_William_Blair_-_FINALLPL_Presentation_-_Q2_2015_William_Blair_-_FINAL
LPL_Presentation_-_Q2_2015_William_Blair_-_FINAL
 
Hindustan Unilever Corporate Finance Analysis Report
Hindustan Unilever Corporate Finance Analysis ReportHindustan Unilever Corporate Finance Analysis Report
Hindustan Unilever Corporate Finance Analysis Report
 
“A STUDY ON FINANCIAL ANALYSIS”
“A STUDY ON FINANCIAL ANALYSIS”“A STUDY ON FINANCIAL ANALYSIS”
“A STUDY ON FINANCIAL ANALYSIS”
 
8Non-GAAPs MeasuresNameProfessor’s NameCourse NameCo.docx
8Non-GAAPs MeasuresNameProfessor’s NameCourse NameCo.docx8Non-GAAPs MeasuresNameProfessor’s NameCourse NameCo.docx
8Non-GAAPs MeasuresNameProfessor’s NameCourse NameCo.docx
 
Financial Performance of Aurabindo.pdf
Financial Performance of Aurabindo.pdfFinancial Performance of Aurabindo.pdf
Financial Performance of Aurabindo.pdf
 

Dr Reddys Analysis V1.1

  • 1. Dr. Reddy’s Laboratories November 28, 2009 Presented by: Group 3 Anshul Gupta Govind Singh Jatinder Pal Singh Puneet Piyush Sachin Sharma Vaibhav Awasthi Submitted to: Prof. A.P. Das
  • 2.
  • 3.
  • 4.
  • 5.